Has Pharmaceutical Innovation Increased Persistence and Adherence of Multiple Sclerosis Patients in Germany?
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.525
https://www.valueinhealthjournal.com/article/S1098-3015(16)31892-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
494
First Page :
A437
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31892-7&doi=10.1016/j.jval.2016.09.525